Titong Sugihartono and Ivan Pratama Alimsardjono and Ummi Maimunah and Iswan Abbas Nusi and Herry Purbayu and Ulfa Kholili and Budi Widodo and Muhammad Miftahussurur and Husin Thamrin and Amie Vidyani and Poernomo Boedi Setiawan (2020) Serum hyaluronic acid and its association with liver stiffness in chronic hepatitis B patients. EurAsian Journal of BioSciences, 14 (1). pp. 1745-1749. ISSN 1307-9867

	Text (Artikel) 26. Serum Hyaluronic Acid and Its Association with Liver Stiffness in Chronic Hepatitis b Patients.pdf Download (311kB)
	Text (Peer Review) 26. Serum Hyaluronic.pdf Download (849kB)
	Text (Similarity) 26. Serum Hyaluronic Acid and Its Association with Liver Stiffness in Chronic Hepatitis b Patients.pdf Download (1MB)

Abstract

Background: Serum hyaluronic acid has an important role in the pathogenesis of liver fibrosis and is one of the most studied extracellular liver matrices. The purpose of this study was to examine the relationship between serum hyaluronic acid level and liver stiffness in hepatitis B chronic patients. Methods: This was an observational cross-sectional analytic study consisting of 43 samples of chronic hepatitis B patients. Serum hyaluronic acid was measured by the ELISA method. Liver stiffness describing fibrosis was examined using Fibro scan. Results: Among forty-three subject was predominantly by females (65.1%). The average age of the study subjects was 44.023 years old. The median serum hyaluronic acid level of the study subjects was 40.318 ng/mL. The median liver stiffness in the study subjects was 5.8 kPa. There was a significant positive correlation between serum hyaluronic acid levels and liver stiffness in the study subjects with a moderate strength of r = 0.448 (P = 0.003). Conclusion: Serum hyaluronic acid levels associated with liver stiffness.

Actions (login required)

View Item